Strikingly, RGS17 expression showed the highest level in prostate cancer among tens of different cancer types in over 10,000 tumor samples (Supplementary Fig. 9a, b), further supporting that RGS17 is a plausible prostate cancer susceptibility gene. Here, RGS17 is linked to prostate carcinoma.